T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.81B |
| 2 |
XYZ
Block Inc
XYZ
|
+$1.46B |
| 3 |
Accenture
ACN
|
+$1.23B |
| 4 |
Gilead Sciences
GILD
|
+$1.15B |
| 5 |
Valero Energy
VLO
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.61B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.06B |
| 3 |
Tesla
TSLA
|
+$1.81B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.72B |
| 5 |
Amazon
AMZN
|
+$1.59B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.44% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 12.3% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Willis Towers Watson
WTW
$31B
| $62.7M | 0.01% |
185,413
-752
| -0.4% | -$245K |
|
652
Onto Innovation
ONTO
$20.6B
| $62.5M | 0.01% |
515,169
-8,505
| -2% | -$1.43M |
|
653
T. Rowe Price Growth Stock ETF
TGRW
$1.04B
| $62.4M | 0.01% |
1,745,001
| – | – |
|
654
Edwards Lifesciences
EW
$53.4B
| $62.3M | 0.01% |
859,694
-2,438,028
| -74% | -$175M |
|
655
First Advantage
FA
$3.81B
| $62.1M | 0.01% |
4,409,427
+2,940,155
| +200% | +$49.4M |
|
656
Celldex Therapeutics
CLDX
$3.35B
| $61.9M | 0.01% |
3,410,499
-146,637
| -4% | -$3.28M |
|
657
Agilent Technologies
A
$42.2B
| $61.7M | 0.01% |
527,416
-572,952
| -52% | -$77.2M |
|
|
CCC
658
CCC Intelligent Solutions
CCC
$4.19B
| $61.7M | 0.01% |
6,827,626
-3,009,728
| -31% | -$31.3M |
|
659
T. Rowe Price Dividend Growth ETF
TDVG
$1.45B
| $61.6M | 0.01% |
1,525,001
| – | – |
|
660
Procept Biorobotics
PRCT
$1.26B
| $61.5M | 0.01% |
1,055,762
+341,906
| +48% | +$23.3M |
|
661
Lamar Advertising Co
LAMR
$15.8B
| $61.2M | 0.01% |
537,628
-72,507
| -12% | -$8.83M |
|
662
Apple Hospitality REIT
APLE
$3.75B
| $61.2M | 0.01% |
4,737,665
-3,501,396
| -42% | -$51.2M |
|
663
ON Semiconductor
ON
$31.8B
| $61.1M | 0.01% |
1,502,700
+728,177
| +94% | +$36.6M |
|
664
Simpson Manufacturing
SSD
$8B
| $61.1M | 0.01% |
388,778
+2,335
| +0.6% | +$383K |
|
665
Unilever
UL
$135B
| $60.9M | 0.01% |
908,844
-186,800
| -17% | -$12.1M |
|
666
StoneX
SNEX
$8.05B
| $60.4M | 0.01% |
1,779,687
+63,668
| +4% | +$2.14M |
|
667
Exelixis
EXEL
$12.5B
| $59.8M | 0.01% |
1,618,518
-148,323
| -8% | -$5.29M |
|
668
Public Service Enterprise Group
PEG
$37.8B
| $59.6M | 0.01% |
724,434
+10,750
| +2% | +$897K |
|
669
Denali Therapeutics
DNLI
$3.97B
| $59.4M | 0.01% |
4,367,234
+1,308,619
| +43% | +$25.1M |
|
670
Colliers International
CIGI
$5.41B
| $59.3M | 0.01% |
488,731
+30,162
| +7% | +$3.95M |
|
671
Axalta
AXTA
$7.93B
| $59.2M | 0.01% |
1,785,263
+21,290
| +1% | +$757K |
|
672
Beam Therapeutics
BEAM
$2.74B
| $59.1M | 0.01% |
3,026,701
+1,273,559
| +73% | +$33.4M |
|
673
Delta Air Lines
DAL
$60B
| $58.9M | 0.01% |
1,349,834
-132,327
| -9% | -$7.84M |
|
|
KRMN
674
Karman Holdings
KRMN
$8.02B
| $58.8M | 0.01% |
+1,759,356
| New | +$56.8M |
|
675
NiSource
NI
$20.2B
| $58.7M | 0.01% |
1,464,599
-790,913
| -35% | -$30.5M |
|
Similar funds
T. Rowe Price Associates's Q1 2025 Portfolio in Review
As of Q1 2025, T. Rowe Price Associates held 3,109 positions worth $812B, down 6.4% from $867B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2025 filing shows 91 new, 2,002 increased, 738 reduced and 70 closed positions. Its largest new stake was T. Rowe Price Value ETF: 8,943,567 shares worth $283M. The largest sale was NVIDIA, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2025 buy was T. Rowe Price Value ETF: 8,943,567 shares worth $283M.
- T. Rowe Price Associates added most to Broadcom in Q1 2025, an estimated $3.81B increase.
- T. Rowe Price Associates's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $4.61B.
- T. Rowe Price Associates fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $271M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $812B portfolio in Q1 2025.
- T. Rowe Price Associates opened 91 new positions and closed 70 in Q1 2025.
- T. Rowe Price Associates's portfolio value fell 6.4% quarter-over-quarter to $812B.
Based on T. Rowe Price Associates's 13F filing for Q1 2025, filed 14 May 2025.